We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Opko Health Inc | NASDAQ:OPK | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.02 | 1.64% | 1.24 | 1.25 | 1.26 | 1.26 | 1.22 | 1.22 | 1,947,676 | 00:42:46 |
1. Name and Address of Reporting Person * FROST PHILLIP MD ET AL | 2. Issuer Name and Ticker or Trading Symbol Opko Health, Inc. [ OPK ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner __X__ Officer (give title below) _____ Other (specify below) CEO & Chairman |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 3068951 | D | ||||||||
Common Stock | 5/26/2020 | P | 50000 | A | $2.31 | 189721694 | I | See Footnote (1) | ||
Common Stock | 5/26/2020 | P | 4850 | A | $2.335 | 189726544 | I | See Footnote (1) | ||
Common Stock | 5/26/2020 | P | 5700 | A | $2.339 | 189732244 | I | See Footnote (1) | ||
Common Stock | 5/26/2020 | P | 39450 | A | $2.34 | 189771694 | I | See Footnote (1) | ||
Common Stock | 5/26/2020 | P | 341 | A | $2.345 | 189772035 | I | See Footnote (1) | ||
Common Stock | 5/26/2020 | P | 22319 | A | $2.35 | 189794354 | I | See Footnote (1) | ||
Common Stock | 5/26/2020 | P | 1000 | A | $2.3597 | 189795354 | I | See Footnote (1) | ||
Common Stock | 5/26/2020 | P | 26340 | A | $2.36 | 189821694 | I | See Footnote (1) | ||
Common Stock | 5/26/2020 | P | 300 | A | $2.3625 | 189821994 | I | See Footnote (1) | ||
Common Stock | 5/26/2020 | P | 11776 | A | $2.365 | 189833770 | I | See Footnote (1) | ||
Common Stock | 5/26/2020 | P | 9336 | A | $2.37 | 189843106 | I | See Footnote (1) | ||
Common Stock | 5/26/2020 | P | 20541 | A | $2.375 | 189863647 | I | See Footnote (1) | ||
Common Stock | 5/26/2020 | P | 700 | A | $2.379 | 189864347 | I | See Footnote (1) | ||
Common Stock | 5/26/2020 | P | 44274 | A | $2.38 | 189908621 | I | See Footnote (1) | ||
Common Stock | 5/26/2020 | P | 1430 | A | $2.385 | 189910051 | I | See Footnote (1) | ||
Common Stock | 5/26/2020 | P | 11643 | A | $2.39 | 189921694 | I | See Footnote (1) | ||
Common Stock | 30127177 | I | See Footnote (2) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
FROST PHILLIP MD ET AL OPKO HEALTH, INC. 4400 BISCAYNE BLVD. MIAMI, FL 33137 | X | X | CEO & Chairman | ||
Frost Gamma Investments Trust 4400 BISCAYNE BLVD. MIAMI, FL 33137 | X |
Signatures | ||
Phillip Frost, M.D., Individually and as Trustee | 5/27/2020 | |
**Signature of Reporting Person | Date |
1 Year Opko Health Chart |
1 Month Opko Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions